Raia Drogasil SA
OTC:RADLY
Gross Margin
Gross Margin shows how much money a company keeps from each dollar of sales after paying for the products it sells. It tells how profitable the company`s core business is before other expenses.
Gross Margin shows how much money a company keeps from each dollar of sales after paying for the products it sells. It tells how profitable the company`s core business is before other expenses.
Peer Comparison
| Country | Company | Market Cap |
Gross Margin |
||
|---|---|---|---|---|---|
| BR |
|
Raia Drogasil SA
BOVESPA:RADL3
|
44.5B BRL |
Loading...
|
|
| ZA |
C
|
Clicks Group Ltd
JSE:CLS
|
76.5B ZAR |
Loading...
|
|
| ZA |
D
|
Dis-Chem Pharmacies Ltd
JSE:DCP
|
30.3B ZAR |
Loading...
|
|
| US |
|
Walgreens Boots Alliance Inc
NASDAQ:WBA
|
10.4B USD |
Loading...
|
|
| JP |
|
Tsuruha Holdings Inc
TSE:3391
|
1.2T JPY |
Loading...
|
|
| JP |
|
MatsukiyoCocokara & Co
TSE:3088
|
1T JPY |
Loading...
|
|
| SA |
|
Al Nahdi Medical Company SCJSC
SAU:4164
|
16.8B SAR |
Loading...
|
|
| CN |
|
Yifeng Pharmacy Chain Co Ltd
SSE:603939
|
30.7B CNY |
Loading...
|
|
| JP |
|
Welcia Holdings Co Ltd
TSE:3141
|
657.7B JPY |
Loading...
|
|
| JP |
S
|
Sugi Holdings Co Ltd
TSE:7649
|
640.3B JPY |
Loading...
|
|
| JP |
|
Cosmos Pharmaceutical Corp
TSE:3349
|
570.5B JPY |
Loading...
|
Market Distribution
| Min | -141.6% |
| 30th Percentile | 21.3% |
| Median | 30.7% |
| 70th Percentile | 43.6% |
| Max | 351.5% |
Other Profitability Ratios
Raia Drogasil SA
Glance View
Raia Drogasil SA, Brazil's pharmaceutical titan, stands as a testament to the transformative power of strategic mergers and innovative retail management. Born out of the merger of Drogasil and Droga Raia, two of Brazil's enduring pharmacy chains, the company today operates an extensive network of retail stores across the nation. This strategic merger in 2011 was not merely a consolidation of operations but a fusion of distinct corporate cultures and expertise, aimed at enhancing operational efficiencies and expanding market share. By leveraging economies of scale, Raia Drogasil has entrenched itself as a formidable force in Brazil's healthcare retail sector, boasting a strong presence in both high-density urban centers and emerging markets in Brazil. The company's business model is built on a robust mix of health and wellness products, encompassing everything from prescription medications to over-the-counter remedies and personal care items. Raia Drogasil has adeptly positioned itself to capitalize on Brazil's growing healthcare demands, thanks to its comprehensive product offerings and strategic store locations. Each store functions as both a destination for health-conscious consumers and a vital link in the greater logistical chain that ensures timely product availability. By intertwining brick-and-mortar retail with digital innovation, Raia Drogasil not only drives revenue through traditional sales channels but also through its dynamic e-commerce platform. This synergy allows the company to tap into the evolving preferences of tech-savvy consumers, thereby making Raia Drogasil a leader in seamlessly integrating shopping experiences that cater to modern customer expectations.
See Also
Gross Margin is calculated by dividing the Gross Profit by the Revenue.
The current Gross Margin for Raia Drogasil SA is 29.4%, which is below its 3-year median of 29.9%.
Over the last 3 years, Raia Drogasil SA’s Gross Margin has decreased from 30.4% to 29.4%. During this period, it reached a low of 29.4% on Jun 30, 2025 and a high of 30.4% on Sep 30, 2022.